Mr. Mackison has over 15 years of pharmaceutical and life sciences experience in corporate development and strategy, mergers and acquisitions and finance and currently serves as Senior Vice President of Corporate Development & Strategy at Assembly Biosciences, Inc.
Prior to Assembly, he was Senior Director, Corporate Investment Life Sciences for Jabil, where he was responsible for healthcare M&A and venture investments. Prior to Jabil, Mr. Mackison founded and served as Managing Director of Oakridge Bioventures, a pharmaceutical strategy and M&A advisory firm, where he advised and co-founded startup companies. Previously, Mr. Mackison served as Divisional Director of Corporate Strategy and Senior Director, New Ventures at Lundbeck in Copenhagen. Prior to Lundbeck, Mr. Mackison was Director, Corporate Development and M&A with Ovation Pharmaceuticals, which was acquired by Lundbeck in 2009. Earlier in his career, Mr. Mackison held positions of increasing responsibility in finance at Pfizer and Eli Lilly and Co. He earned a BS in Finance from Indiana University.